Concepedia

Publication | Open Access

Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales

DOIFull Paper Access

31

Citations

15

References

2022

Year

David Hodgson, Mihály Koltai, Fabienne Krauer, Stefan Flasche, Mark Jit, Katherine E. Atkins
Vaccine

Abstract

Nirsevimab has the potential to be cost-effective in England and Wales not only for use in high-risk infants.

References

YearCitations

Page 1